ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

As von Eschenbach Prepares For New Assignment, NCI’s 2015 Goal Faces Uncertainty. New Strategic Plan Lists Steps to 2015. “The Vision Is Within Our Grasp,” von Eschenbach Says.

March 10, 2006

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991